The Centers for Medicare and Medicaid Services (CMS) announced this week that it would expand coverage for PET scans used in the diagnosis of Alzheimer's disease.
CMS has been hesitant to open reimbursements for the procedure, and the agency has long said that it would only cover one brain scan per beneficiary for a patient's...National News
The U.S. Department of Veterans Affairs (VA) has agreed to pay for the Alzheimer's drug Leqembi, putting pressure on the Medicare program to follow suit.
Leqembi, produced by Japanese pharmaceutical manufacturer Eisai Co. in cooperation with Biogen Inc., was approved by the U.S. Food and Drug Administration (FDA) earlier this year....
